- Home
- AACG vs NEPH Comparison
AACG vs NEPH Comparison
Compare AACG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- NEPH
- Stock Information
- Founded
- AACG 1999
- NEPH 1997
- Country
- AACG China
- NEPH United States
- Employees
- AACG N/A
- NEPH 31
- Industry
- AACG Other Consumer Services
- NEPH Medical/Dental Instruments
- Sector
- AACG Real Estate
- NEPH Health Care
- Exchange
- AACG Nasdaq
- NEPH Nasdaq
- Market Cap
- AACG 51.9M
- NEPH 60.2M
- IPO Year
- AACG N/A
- NEPH 2004
- Fundamental
- Price
- AACG N/A
- NEPH $5.16
- Analyst Decision
- AACG
- NEPH Strong Buy
- Analyst Count
- AACG 0
- NEPH 2
- Target Price
- AACG N/A
- NEPH $5.50
- AVG Volume (30 Days)
- AACG 89.8K
- NEPH 80.6K
- Earning Date
- AACG 11-06-2025
- NEPH 11-06-2025
- Dividend Yield
- AACG N/A
- NEPH N/A
- EPS Growth
- AACG N/A
- NEPH N/A
- EPS
- AACG N/A
- NEPH 0.12
- Revenue
- AACG $39,064,701.00
- NEPH $16,684,000.00
- Revenue This Year
- AACG N/A
- NEPH $24.38
- Revenue Next Year
- AACG N/A
- NEPH $10.16
- P/E Ratio
- AACG N/A
- NEPH $43.29
- Revenue Growth
- AACG 15.19
- NEPH 21.16
- 52 Week Low
- AACG $0.70
- NEPH $1.36
- 52 Week High
- AACG $2.58
- NEPH $5.97
- Technical
- Relative Strength Index (RSI)
- AACG N/A
- NEPH 76.83
- Support Level
- AACG N/A
- NEPH $4.52
- Resistance Level
- AACG N/A
- NEPH $5.97
- Average True Range (ATR)
- AACG 0.00
- NEPH 0.31
- MACD
- AACG 0.00
- NEPH 0.14
- Stochastic Oscillator
- AACG 0.00
- NEPH 91.64
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.